Patient derived renal cell carcinoma xenografts exhibit distinct sensitivity patterns in response to antiangiogenic therapy and constitute a suitable tool for biomarker development
Oncotarget | July 24, 2018 | Volume: 9 | Issue: 57 | Pages: 30946-30961
10.18632/oncotarget.25697
| PMID 30123419